Elena Raspitha

Elena Raspitha serves as a key procurement professional within the Defense Logistics Agency’s Troop Support organization, where she manages critical acquisitions supporting the operational readiness of U.S. military forces. Her responsibilities center on securing specialized in-vitro diagnostic substances and related medical supply systems essential to field medical operations, force health protection, and deployable medical infrastructure. She executes full lifecycle contracting actions for high-integrity, regulatory-compliant products used in expeditionary and garrison medical environments, ensuring alignment with DoD standards for safety, sterility, and rapid deployment. Raspitha maintains consistent working relationships with a select group of specialized manufacturers including WESTLAND TECHNOLOGIES, INC., ENGINEERED COIL COMPANY, ECI DEFENSE GROUP, INC., PIONEER INDUSTRIES, LLC, and AEROSPACE & COMMERCIAL TECHNOLOGIES, LLC. These vendors are recognized for their technical expertise in producing precision-engineered diagnostic reagents, climate-controlled storage systems, and ruggedized medical supply containers. Her contracting approach emphasizes long-term vendor partnerships built on technical reliability, regulatory compliance, and supply chain resilience, often leveraging sole-source or limited competition authorities for mission-critical items. Raspitha’s procurement portfolio reflects a 100% non-set-aside contracting pattern, indicating a focus on technical specificity and industrial capacity over socioeconomic preferences. While small business participation is not formally prioritized in her awards, her selections are driven by the stringent performance and certification requirements inherent to diagnostic substance manufacturing and defense medical logistics. Her primary focus is NAICS 325413 — In-Vitro Diagnostic Substance Manufacturing — where she procures specialized reagents, assay kits, and diagnostic systems used in point-of-care and field-deployable medical testing. Her expertise lies in the acquisition of chemically stable, temperature-sensitive medical products requiring strict chain-of-custody controls and FDA-compliant manufacturing environments, ensuring combat-ready medical diagnostics for deployed forces.